Go Pro
NASDAQ:BKYI

BIO-key International (BKYI) Stock Price, News & Analysis

BIO-key International logo
$5.31 -0.58 (-9.82%)
Closing price 03:59 PM Eastern
Extended Trading
$5.17 -0.14 (-2.66%)
As of 06:25 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About BIO-key International Stock (NASDAQ:BKYI)

Advanced

Key Stats

Today's Range
$4.50
$5.76
50-Day Range
$3.46
$5.99
52-Week Range
$3.10
$19.70
Volume
70,515 shs
Average Volume
168,615 shs
Market Capitalization
$5.76 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Sell

Company Overview

BIO-key International Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
2nd Percentile Overall Score

BKYI MarketRank™: 

BIO-key International scored higher than 2% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    BIO-key International has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    BIO-key International has only been the subject of 1 research reports in the past 90 days.

  • Read more about BIO-key International's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of BIO-key International is -0.69, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of BIO-key International is -0.69, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    BIO-key International has a P/B Ratio of 0.48. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about BIO-key International's valuation and earnings.
  • Short Interest

    There is no current short interest data available for BKYI.
  • Dividend Yield

    BIO-key International does not currently pay a dividend.

  • Dividend Growth

    BIO-key International does not have a long track record of dividend growth.

  • News Coverage This Week

    MarketBeat has tracked 2 news articles for BIO-key International this week, compared to 2 articles on an average week.
  • MarketBeat Follows

    1 people have added BIO-key International to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, BIO-key International insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    3.90% of the stock of BIO-key International is held by insiders.

  • Percentage Held by Institutions

    26.51% of the stock of BIO-key International is held by institutions.

  • Read more about BIO-key International's insider trading history.
Receive BKYI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BIO-key International and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BKYI Stock News Headlines

Is the fix for AI's runaway power problem your golden ticket?
The government just committed $200 billion to building computer chips on American soil - one of the largest technology bets in U.S. history. George Gilder, who has tracked technology signals for over 40 years, believes Washington just tipped its hand. He says this move points to a coming shift in computing that could leave today's machines behind - and most investors have already moved past the headline.tc pixel
See More Headlines

BKYI Stock Analysis - Frequently Asked Questions

BIO-key International's stock was trading at $5.3910 at the beginning of the year. Since then, BKYI shares have decreased by 10.1% and is now trading at $4.8460.

BIO-key International Inc. (NASDAQ:BKYI) posted its earnings results on Tuesday, March, 31st. The technology company reported ($0.19) earnings per share for the quarter, topping the consensus estimate of ($0.70) by $0.51. The technology company had revenue of $1.24 million for the quarter, compared to the consensus estimate of $2.20 million. BIO-key International had a negative trailing twelve-month return on equity of 67.43% and a negative net margin of 75.32%.
Read the conference call transcript
.

Shares of BIO-key International reverse split before market open on Thursday, December 21st 2023.The 1-18 reverse split was announced on Thursday, December 21st 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, December 21st 2023. An investor that had 100 shares of stock prior to the reverse split would have 6 shares after the split.

Shares of BKYI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that BIO-key International investors own include ExxonMobil (XOM), T2 Biosystems (TTOO), Nokia (NOK), Tonix Pharmaceuticals (TNXP) and

Company Calendar

Last Earnings
3/31/2026
Today
7/08/2026
Next Earnings (Estimated)
8/17/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
ELEC PRODS - MISC
Sub-Industry
Computer Software
Current Symbol
NASDAQ:BKYI
CIK
1019034
Employees
50
Year Founded
1993

Profitability

EPS (Trailing Twelve Months)
($5.55)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$4.59 million
Net Margins
-75.32%
Pretax Margin
-67.72%
Return on Equity
-67.43%
Return on Assets
-43.29%

Debt

Debt-to-Equity Ratio
0.17
Current Ratio
1.26
Quick Ratio
1.13

Sales & Book Value

Annual Sales
$6.10 million
Price / Sales
0.95
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$10.15 per share
Price / Book
0.52

Miscellaneous

Outstanding Shares
1,085,000
Free Float
1,043,000
Market Cap
$5.76 million
Optionable
No Data
Beta
0.43

Social Links

7 Stocks to Buy And Hold Forever Cover

Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:BKYI) was last updated on 7/8/2026 by MarketBeat.com Staff.
From Our Partners